Dr. Clifford Sheldon Beck, M.D. Allergy & Immunology - Allergy Medicare: Not Enrolled in Medicare Practice Location: 152 Pioneer Ln, Suite H, Bishop, CA 93514 Phone: 760-873-6373 Fax: 760-873-3266 |
News Archive
Jasco Pharmaceuticals, LLC was awarded a grant under the US Government's Patient Protection and Affordable Care Act (PPACA) of 2010. The grant was related to Jasco Pharma's novel small molecule Pim inhibitor program intended to develop therapeutics for the treatment of cancer.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, today announced results of preclinical studies demonstrating that its clinical candidate, AVL-292, potently inhibits B cell receptor signaling, and demonstrates efficacy in a rodent model of rheumatoid arthritis. These new data were presented Saturday, June 26, 2010 at the Federation of Clinical Immunology Societies (FOCIS) 2010 annual meeting in Boston, MA.
Democrats again reach 60 seats in the Senate with the announcement of Ted Kennedy's interim replacement. The Los Angeles Times reports that Massachusetts Gov. Deval Patrick "named Paul Kirk Jr., a former Democratic National Committee chairman and close friend and former aide of the late Sen. Edward M. Kennedy, to serve as a temporary replacement for the deceased senator until a special election for the seat is held in January."
Xhale Innovations, a leading provider of patient safety technology, announced today the results of a study presented by Miami Children's Hospital at the Annual Society for Healthcare Epidemiology of America Conference on the HyGreen Hand Hygiene Reminder System.
Researchers in the United States and Japan have provided novel insights into the pathologic mechanisms underlying coronavirus disease 2019 (COVID-19) that may aid the identification of potential diagnostic biomarkers and treatment targets.
› Verified 4 days ago